DAIHAN Scientific Co. Ltd (131220) - Cash Flow Conversion Efficiency
Based on the latest financial reports, DAIHAN Scientific Co. Ltd (131220) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩361.12 Million ≈ $244.72K USD) by net assets (₩56.60 Billion ≈ $38.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
DAIHAN Scientific Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how DAIHAN Scientific Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 131220 current and long-term liabilities for a breakdown of total debt and financial obligations.
DAIHAN Scientific Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DAIHAN Scientific Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
2B INTELLIGENT SOFT S.A.
RO:BENTO
|
N/A |
|
Seafresh Industry Public Company Limited
BK:CFRESH
|
0.070x |
|
CEO Event Medya AS
IS:CEOEM
|
0.288x |
|
Korea SE Corp
KQ:101670
|
-0.024x |
|
TherapeuticsMD Inc
NASDAQ:TXMD
|
0.038x |
|
Silvair Inc
WAR:SVRS
|
0.106x |
|
JPMorgan American Investment Trust
LSE:JAM
|
0.003x |
|
Ropharma Bras
RO:RPH
|
0.057x |
Annual Cash Flow Conversion Efficiency for DAIHAN Scientific Co. Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of DAIHAN Scientific Co. Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see DAIHAN Scientific Co. Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩42.22 Billion ≈ $28.61 Million |
₩3.99 Billion ≈ $2.70 Million |
0.094x | -22.76% |
| 2023-12-31 | ₩39.20 Billion ≈ $26.56 Million |
₩4.79 Billion ≈ $3.25 Million |
0.122x | -1.28% |
| 2022-12-31 | ₩36.43 Billion ≈ $24.69 Million |
₩4.51 Billion ≈ $3.06 Million |
0.124x | -2.21% |
| 2021-12-31 | ₩32.63 Billion ≈ $22.11 Million |
₩4.13 Billion ≈ $2.80 Million |
0.127x | -30.77% |
| 2020-12-31 | ₩29.22 Billion ≈ $19.80 Million |
₩5.35 Billion ≈ $3.62 Million |
0.183x | +111.86% |
| 2019-12-31 | ₩28.24 Billion ≈ $19.14 Million |
₩2.44 Billion ≈ $1.65 Million |
0.086x | -41.05% |
| 2018-12-31 | ₩25.65 Billion ≈ $17.38 Million |
₩3.76 Billion ≈ $2.55 Million |
0.146x | -23.24% |
| 2017-12-31 | ₩24.00 Billion ≈ $16.27 Million |
₩4.58 Billion ≈ $3.10 Million |
0.191x | +7.87% |
| 2016-12-31 | ₩23.31 Billion ≈ $15.80 Million |
₩4.12 Billion ≈ $2.79 Million |
0.177x | +354.44% |
| 2015-12-31 | ₩23.07 Billion ≈ $15.64 Million |
₩898.12 Million ≈ $608.65K |
0.039x | -66.72% |
| 2014-12-31 | ₩22.14 Billion ≈ $15.00 Million |
₩2.59 Billion ≈ $1.76 Million |
0.117x | +268.14% |
| 2012-12-31 | ₩17.81 Billion ≈ $12.07 Million |
₩565.94 Million ≈ $383.53K |
0.032x | -- |
About DAIHAN Scientific Co. Ltd
DAIHAN Scientific Co., Ltd. manufactures and supplies laboratory instruments and medical devices in South Korea and internationally. It offers autoclaves, balances, centrifuges, evaporators, gel documentation systems, heating stirrers, mills, shakers, viscometers, refrigerators/freezers, bath circulators, chillers/cooling circulators, freeze dry systems, glass/labware washers, heating mantles, ho… Read more